{"id":966,"date":"2026-07-16T00:09:55","date_gmt":"2026-07-15T22:09:55","guid":{"rendered":"https:\/\/www.pharmarome.fr\/pharmaceutique\/"},"modified":"2026-07-23T16:01:52","modified_gmt":"2026-07-23T14:01:52","slug":"pharmaceutical","status":"publish","type":"page","link":"https:\/\/www.pharmarome.fr\/en\/pharmaceutical\/","title":{"rendered":"Pharmaceutical"},"content":{"rendered":"

PHARMACEUTICAL<\/h1>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>

Pharmaceutical Market: a sector where taste drives treatment adherence<\/h2>\n<\/div><\/div><\/div><\/div><\/div>
<\/div>

The pharmaceutical flavouring market is experiencing steady growth, driven by increasing demand for more acceptable and better-tolerated formulations.<\/p>\n

Today, flavouring has become a key strategic tool<\/strong> for improving medicine acceptability, particularly for oral dosage forms (syrups, solutions, powders, chewable tablets, etc.).<\/p>\n

Scientific data confirms that taste is no longer a secondary consideration, but a key parameter in pharmaceutical development.<\/p>\n<\/div><\/div><\/div><\/div>

\"\"<\/div><\/div><\/div><\/div><\/div>
<\/div>
\"\"<\/div><\/div><\/div><\/div>

A study by the European Society of Medicine highlights that 65% of active pharmaceutical ingredients (APIs) exhibit bitterness<\/strong>, requiring dedicated taste-masking strategies. It also shows that most APIs present multiple aversive attributes (off-notes, unpleasant smells, irritation), increasing the sensory complexity of oral formulations.<\/p>\n

At a global level, several analyses confirm that pharmaceutical flavourings represent a multi-billion-dollar market<\/strong>, driven by rising expectations for palatability, particularly in paediatric and OTC formulations. Most studies indicate annual growth rates between 4% and 7%<\/strong>, reflecting sustained and long-term momentum.<\/p>\n<\/div><\/div><\/div><\/div><\/div>

<\/div>

Taste has become a decisive factor in therapeutic effectiveness and the commercial success of oral dosage forms.<\/strong><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>

\"\"<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div>

A HIGHLY DEMANDING MARKET WITH SPECIFIC CONSTRAINTS<\/h2>\n<\/div><\/div><\/div><\/div><\/div>
<\/div>

The pharmaceutical sector is characterised by unique requirements:<\/p>\n<\/div><\/div><\/div><\/div><\/div>

<\/div>
\"\"<\/div>

STRICT REGULATORY CONSTRAINTS<\/h3>

legal naming, EU and international compliance, usage restrictions<\/p>\n<\/div><\/div><\/div><\/div><\/div>

\"\"<\/div>

HIGH QUALITY REQUIREMENTS<\/h3>

Certificates of Analysis (CoA), specifications, traceability, batch compliance<\/p>\n<\/div><\/div><\/div><\/div><\/div>

\"\"<\/div>

PROCESS AND DOSAGE FORM CONSTRAINTS<\/h3>

solubility, stability, API interactions, manufacturing conditions<\/p>\n<\/div><\/div><\/div><\/div><\/div>

\"\"<\/div>

HIGH SENSORY REQUIREMENTS<\/h3>

bitterness, off-notes, flavour consistency over time<\/p>\n<\/div><\/div><\/div><\/div><\/div>

\"\"<\/div>

DIVERSE INTERNAL STAKEHOLDERS<\/h3>

R&D, Quality, Regulatory Affairs, Procurement<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div>

This market requires a partner capable of combining rigour, robust documentation, strong sensory performance and deep understanding of industrial constraints.<\/p>\n<\/div><\/div><\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div><\/section>
<\/div>
\"\"<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div>

HOW WE SUPPORT PHARMACEUTICAL STAKEHOLDERS<\/h2>\n<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/section>